Please wait a minute...
7Drug Combination Therapy  2019, Vol. 1 Issue (3): 134-152    DOI: 10.12032/DCT201904002
Orginal Article     
A network pharmacological study on the potential mechanism of Yinchenhao Decoction in treatment of chronic hepatitis B
Jin-Yu Zhang1, Xian-Fa Cai2*
1. School of Public Health, Guangdong Pharmaceutical University, Guangzhou, 510310, China.  2. School of Medical Information Engineering, Guangdong Pharmaceutical University, Guangzhou, 510006, China.
Download:   PDF(1206KB)
Export: BibTeX | EndNote (RIS)      

Background: Yinchenhao Decoction (YCHD), an ancient Chinese herbal medicinal compound prescribe for the treatment of jaundice, which long-term clinical experience and randomized trials have shown was effective against chronic hepatitis B (CHB). However, its mechanism remained unknown. With the gradual separation of pharmacodynamic components in YCHD and the development of computer virtual technology, network pharmacology provides an opportunity. Our study is to explore the underlying mechanism of YCHD for the treatment of CHB. Methods: The active compounds of YCHD were screened from TCMSP database, whose targets were predicted based on the ligands structures and the targets of CHB was selected from the TTD, DisGeNET, and Drugbank databases to obtain the potential targets of YCHD for CHB treating. Cytoscape 3.6.1 was applied for network analysis to identify key targets, and gene enrichment of the targets shared by both YCHD and CHB was performed by DAVID database. The virtual verification of binding activities between the target protein and the small molecule was finally performed by the Sytems Dock platform. Results: The potentially important targets associated with CHB corresponding to 33 compound components from YCHD included ESR1, CYP1A2, PTGS2, CYP1A1, ABCG2, MMP9. Besides, enriched were the related 8 KEGG pathways (P<0.05) such as ABC transporters, Bile secretion, TNF signaling pathway. Conclusions: This study used network pharmacology method to reveal the characteristics, “multi-component and multi-target and multi-pathway”, of YCHD on CHB treatment, providing thoughts for further research.



Key wordsNetwork pharmacology      Yinchenhao Decoction      Chronic hepatitis B     
Received: 12 June 2019      Published: 08 August 2019
Fund:  

This study was supported by the PhD Start-up Fund of Natural Science Foundation of Guangdong Province (No.2015A030310267).

Corresponding Authors: Xian-Fa Cai, School of Medical Information Engineering, Guangdong Pharmaceutical University, Guangzhou, 510006, China.    
E-mail: cxianfa@126.com.
Cite this article:

Jin-Yu Zhang, Xian-Fa Cai . A network pharmacological study on the potential mechanism of Yinchenhao Decoction in treatment of chronic hepatitis B. 7Drug Combination Therapy, 2019, 1(3): 134-152. doi: 10.12032/DCT201904002

URL:

https://www.tmrjournals.com/dct/EN/10.12032/DCT201904002     OR     https://www.tmrjournals.com/dct/EN/Y2019/V1/I3/134

[1] Xian-Jun Wu, Xin-Bin Zhou, Chen Chen, Wei Mao. Dissecting the underlying pharmaceutical mechanism of traditional Chinese medicine Wenxin Keli acting on atrial fibrillation through network pharmacology[J]. 7Drug Combination Therapy, 2019, 1(3): 117-133.
[2] Yu-Zhi Shang, Qing-Huai Zhang, Qiu-Xia Chen, Xiu-Song Tang, Yu-Zhou Pang, Gang Fang. Research trends and development status of TCM network pharmacology: a bibliometric study[J]. 7Drug Combination Therapy, 2019, 1(3): 102-116.